Todos Medical Ltd. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

LOSS PER ORDINARY SHARE

LOSS PER ORDINARY SHARE

12 Months Ended

Dec. 31, 2016

NOTE 16 LOSS PER ORDINARY SHARE

The loss and the weighted average number of ordinary shares used in computing basic and diluted loss per ordinary share for the years ended December 31, 2016, 2015 and 2014, are as follows:

	Year ended December 31
	2016		2015		2014
	US Dollars

Loss for the year		653,461		818,541		322,067
Less: Loss attributed to preferred shares		32,483		51,084		30,721
Loss for the year attributable to ordinary shareholders		620,978		767,457		291,346

	Year ended December 31
	2016		2015		2014
	Number of shares

Weighted average number of ordinary shares outstanding attributable to ordinary shareholders		62,467,556		45,190,017		28,450,908

During the years ended December 31, 2016 and 2015, 4,518,406 and 3,106,000, three year warrants, respectively, were issued - as described in Note 7. These warrants are participating securities as described in Note 2.J., but were not taken into account in calculating either the basic or diluted loss per ordinary share, as their effect was anti-dilutive. During the years ended December 31, 2015 and 2014 there were no other potential instruments (except for the convertible preferred shares).

During the year ended December 31, 2016, the total weighted average number of ordinary shares related to outstanding options and warrants excluded from the calculation of the diluted loss per share was 1,182,066.